Navigation Links
Patients Dissatisfied Following Closed Reduction Of Nasal Fractures

A report in the January/February issue of Archives of Facial Plastic Surgery, one of the JAMA/Archives journals, finds that nearly one-third of the patients who underwent closed reduction of nasal fractures //reported dissatisfaction with the outcome and said they would consider further surgery to correct their nasal deformities.

Closed reduction, the standard procedure to repair a broken nose, involves repositioning nasal bones without an open surgical incision. It is typically performed within seven days of nasal fracture for children and within 10 days for adults.

'This method, although simple, fails to address deformities of the cartilaginous framework and the nasal septum caused by the injury,' the authors write. 'Increasing evidence shows that patients have persistent aesthetic concerns about the outcome and obstructive symptoms after closed reductions.'

Terry Hung, M.B.Chir, F.R.C.S., and colleagues at The Chinese University of Hong Kong, Prince of Wales Hospital, interviewed 62 patients who underwent a closed reduction between July 1, 2002, and June 30, 2005. The interviews assessed patients' satisfaction and the severity of their deformity aesthetically and functionally both before and after the procedure. Satisfaction and severity were assessed on a scale from one to five, with one being very satisfied or least severe and five being very dissatisfied and most severe.

Fifty patients (81 percent) were male and 12 (19 percent) were female, and they had an average age of 27.7 years. Forty-five percent of nasal fractures were caused by sports injuries, 23 percent by physical altercations or assaults and 10 percent by motor vehicle crashes. The average score for nasal deformity was 3.08 before surgery and 1.62 after surgery, the average score for aesthetic concern was 2.97 before surgery and 1.54 following, and the average score for nasal obstruction was 2.03 before surgery and 1.36 after surgery. Following the cl
'"/>




Page: 1 2

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patients often assume wrongly that they are allergic to penicillin
7. New FDA Approved Drug NATRECOR For Heart Failure Patients
8. Hemochromatosis Patients Blood is Safe
9. Patients Pressure Would Result In Overprescription
10. Risk Of Decongestants In Hypertensive Patients
11. Interference helps Heart Patients
Post Your Comments:
(Date:12/2/2008)...minder, the nation,s leading,comprehensive patien...dustry,technology today at Javits Center in New Y...and distributing video testimonials can be used to...pular platforms such as YouTube, Google,Videos an...h an effective,business strategy for increasing n...
(Date:12/2/2008)...re/ -- Seniors, disabled,Michiganders, state HMOs...,oppose efforts by Blue Cross to jam anti-consumer... session of the Legislature. , "This could ...higan," said,RoAnne Chaney, Health Policy Manager... vote for this bill is a vote to dramatically rais...
(Date:12/2/2008)...er ranks No. 1 nationwide for the speed with which...ngioplasty, according to the National Cardiovascul... (Vocus) December 2, 2008 -- UCSF Medical Center ...art attack patients are treated using balloon angi...Data Registry (NCDR). Cardiac balloon angioplasty...
(Date:12/2/2008)...nited American Healthcare,Corporation (Nasdaq: ...thcare,management services to a managed care orga...oard of Directors has approved a share repurchase ... to $1.0 million of its outstanding,common stock....mon shares to be purchased in the,open market at ...
Breaking Medicine News(10 mins):Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 3Health News:Opposition Continues to Grow to Blues' Legislation 2Health News:Opposition Continues to Grow to Blues' Legislation 3Health News:UCSF Medical Center Leads Nation in ER Heart Attack Care 2Health News:UCSF Medical Center Leads Nation in ER Heart Attack Care 3Health News:United American Healthcare Corporation Announces Stock Repurchase Program 2
...confrontations with husbands may mean bad news for...//increase the risk of death from any cause, espec...Boston University had collected data on the marita...omen to find out how far the stress in marriages c...
...the expression of a gene called BRCC36 in cells of...tion //therapy. The gene BRCA1 is the one that is ...r, and expression of BRCC36 inhibits the former pr...levated levels of BRCC36 when compared to normal b...
...nt study made by researchers of UK, scientists hav...//oxygen level in the blood of the passengers. The...h has become so commonplace today, do have any eff...lying today. The researchers have taken the measur...
...full term pregnancy at the age of 20yrs may be the...hers from Fox Chase Cancer Center in Philadelphia ...ty only after a full term pregnancy. Once the cell... to cancer and earlier the women become pregnant t...
Other Medicine News:
(Date:11/30/2008)...ire-USNewswire/ -- Older adults who exercise regul...ter number of small blood vessels in the brain, ac...meeting of the Radiological Society of North Ameri... University of North Carolina ( UNC) - Chapel Hi...adults who exercise to brain scans of those who do...
(Date:11/27/2008)...e lymphoblastic leukemia relapse cases arise from ... , MEMPHIS, Tenn., Nov. 27 /PRNewswire-USNew...ch Hospital have identified distinctive genetic ch...ymphoblastic leukemia (ALL) that cause relapse. Th... for ALL relapse in children and, ultimately, in a...
(Date:11/25/2008)...ry , , Audio and Web Video Resources to acc... News Blog. Please see the bottom of this release .... 25 A Mayo Clinic stud...they,re having a stroke -- and as a result -- dela... The findings appear in the current issue of Emerg...
(Date:11/25/2008)... Poniard,Pharmaceutical...pany focused on,innovative oncology therapies, an... alternatives for its preclinical research program...urces on the clinical development of picoplatin,...tial commercialization of,picoplatin in the treat...
Breaking Medicine Technology:Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3SXC Health Solutions announces third quarter financial results 28943 1SXC Health Solutions announces third quarter financial results 28943 2SXC Health Solutions announces third quarter financial results 28943 3SXC Health Solutions announces third quarter financial results 28943 4SXC Health Solutions announces third quarter financial results 28943 5SXC Health Solutions announces third quarter financial results 28943 6SXC Health Solutions announces third quarter financial results 28943 7SXC Health Solutions announces third quarter financial results 28943 8SXC Health Solutions announces third quarter financial results 28943 9SXC Health Solutions announces third quarter financial results 28943 10SXC Health Solutions announces third quarter financial results 28943 11SXC Health Solutions announces third quarter financial results 28943 12SXC Health Solutions announces third quarter financial results 28943 13SXC Health Solutions announces third quarter financial results 28943 14SXC Health Solutions announces third quarter financial results 28943 15SXC Health Solutions announces third quarter financial results 28943 16SXC Health Solutions announces third quarter financial results 28943 17SXC Health Solutions announces third quarter financial results 28943 18SXC Health Solutions announces third quarter financial results 28943 19SXC Health Solutions announces third quarter financial results 28943 20PAREXEL Expands Pioneering Asian Ethnobridging Expertise 8936 1PAREXEL Expands Pioneering Asian Ethnobridging Expertise 8936 2PAREXEL Expands Pioneering Asian Ethnobridging Expertise 8936 3PAREXEL Expands Pioneering Asian Ethnobridging Expertise 8936 4PAREXEL Expands Pioneering Asian Ethnobridging Expertise 8936 5Leading Spanish Health Service Provider Selects Autonomy for Innovation in Healthcare 28936 1Leading Spanish Health Service Provider Selects Autonomy for Innovation in Healthcare 28936 2Leading Spanish Health Service Provider Selects Autonomy for Innovation in Healthcare 28936 3Leading Spanish Health Service Provider Selects Autonomy for Innovation in Healthcare 28936 4LocumTenens com Finds Psychiatrists are Neutral on Universal Healthcare 28934 1LocumTenens com Finds Psychiatrists are Neutral on Universal Healthcare 28934 2LocumTenens com Finds Psychiatrists are Neutral on Universal Healthcare 28934 3
...roof of concept in topical models of,infection , R... Ltd.,(SWX: ARPN) today announced positive results...against a large panel of,clinical isolates, includ...In addition, topical applications of AR-2474 were ...illin resistant,Staphylococcus aureus (MRSA) in pr...
... 2007--The World Health Organization,has released ...in,Pakistan. , So is this another instance where, ...ical industry is denying important vaccines to,poo... London’s Guardian,newspaper, “parents...o allow health workers to administer polio vaccina...
Other Medicine Technology:Arpida adds novel antibiotic AR-2474 to its preclinical pipeline 2Arpida adds novel antibiotic AR-2474 to its preclinical pipeline 3Why Is Polio Spreading in Pakistan? 2
For the quantitative in vitro determination of IgG in serum and plasma. This product is suitable for use on the Aeroset
The URCA (Uric acid) method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of uric acid in serum, plasma and urine.
For the quantitative determination of apolipoprotein B (apo B) in serum and plasma.
The XTRI method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of triglycerides in serum and plasma.
Medicine Products: